有前途的天然产品向蛋白氨酸酸酶SHP2用于癌症治疗
Jiani Lu1, Danmei Yu1, Hongtao Li1
1Shanghai Frontiers Science Center of TCM Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Phytotherapy research : PTR
|April 1, 2024
概括
针对含有蛋白氨酸酸酶-2 (SHP2) 的Src同质-2域的天然产品作为抗瘤药物表现有前途. 这篇评论详细介绍了它们在癌症治疗中的潜力,通过调节瘤微环境和免疫反应.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 含有蛋白氨酸酸酶-2 (SHP2) 抑制剂的 Src 同型-2 域在抗瘤药物开发中至关重要.
- SHP2在瘤微环境调节和抗瘤免疫反应中发挥作用.
- 天然产品提供了各种各样的化合物,有可能针对SHP2及其突变.
研究的目的:
- 审查自然产品的多样性,生物化学和治疗潜力,以向癌症中的SHP2.
- 总结这些天然产品的结构,分类和抑制作用.
- 探索它们在各种癌症中的抗瘤作用和机制.
主要方法:
- 对针对SHP2.2的天然产品研究的文献综述.
- 对SHP2抑制剂结构,活动和实验模型的分析.
- 对药理机制和抗瘤功效的评估.
主要成果:
- 一些SHP2抑制剂,包括天然产品衍生品,正在临床试验中,用于高级固体瘤.
- 自然化合物影响瘤细胞的增殖,亡,迁移和免疫细胞的激活.
- 自然产品对SHP2的向影响了与癌症相关的关键信号通路.
结论:
- 针对SHP2的天然产品代表了开发新型抗癌药物的有希望的途径.
- 对它们的有效性和机制的进一步研究可以指导未来的治疗策略.
- 本综述提供了一个全面的概述,以促进SHP2向癌症治疗的发展.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


